Abstract:Introduction: Tuberculosis (TB) is an infectious disease caused by the group of bacterial pathogens Mycobacterium tuberculosis complex (MTBC) and is one of the leading causes of death worldwide. Timely diagnosis and treatment of drug-resistant TB is a key pillar of WHO's strategy to combat global TB. The time required to carry out drug susceptibility testing (DST) for MTBC via the classic culture method is in the range of weeks and such delays have a detrimental effect on treatment outcomes. Given that molecular testing is in the range of hours to 1 or 2 days its value in treating drug resistant TB cannot be overstated. When developing such tests, one wants to optimize each step so that tests are successful even when confronted with samples that have a low MTBC load or contain large amounts of host DNA. This could improve the performance of the popular rapid molecular tests, especially for samples with mycobacterial loads close to the limits of detection. Where optimizations could have a more significant impact is for tests based on targeted next generation sequencing (tNGS) which typically require higher quantities of DNA. This would be significant as tNGS can provide more comprehensive drug resistance profiles than the relatively limited resistance information provided by rapid tests. In this work we endeavor to optimize pre-treatment and extraction steps for molecular testing. Methods: We begin by choosing the best DNA extraction device by comparing the amount of DNA extracted by five commonly used devices from identical samples. Following this, the effect that decontamination and human DNA depletion have on extraction efficiency is explored. Results: The best results were achieved (i.e., the lowest C t values) when neither decontamination nor human DNA depletion were used. As expected, in all tested scenarios the addition of decontamination to our workflow substantially reduced the yield of DNA extracted. This illustrates that the standard TB laboratory practice of applying decontamination, although being vital for culture-based testing, can negatively impact the performance of molecular testing. As a complement to the above experiments, we also considered the best Mycobacterium tuberculosis DNA storage method to optimize molecular testing carried out in the near- to medium-term. Comparing C t values following three-month storage at 4 °C and at −20 °C and showed little difference between the two. Discussion: In summary, for molecular diagnostics aimed at mycobacteria this work highlights the importance of choosing the right DNA extraction device, indicates that decontamination causes significant loss of mycobacterial DNA, and shows that samples preserved for further molecular testing can be stored at 4 °C, just as well at −20 °C. Under our experimental settings, human DNA depletion gave no significant improvement in C t values for the detection of MTBC.

Development of effective antimicrobial cocktails to prevent bacterial contamination of allograft tissues under low temperature conditions

Residual Antibiotics in Decontaminated Human Cardiovascular Tissues Intended for Transplantation and Risk of Falsely Negative Microbiological Analyses

Effective of different industrial disinfection in subzero cold-chain environment

Micro-environment-triggered chemodynamic treatment for boosting bacteria elimination at low-temperature by synergistic effect of photothermal treatment and nanozyme catalysis

Investigating the Influence of Temperature and Supplementation Timing on Antifungal Efficacy in Storage Medium for Corneal Transplantation

Low temperature storage and grafting of human ovarian tissue

Development and Validation of Liquid Chromatographic Method for Fast Determination of Lincomycin, Polymyxin and Vancomycin in Preservation Solution for Transplants

Enhanced Osteogenesis of Polyvinylpyrrolidone-Iodine As a Sterilizing Agent for Preservation of Allografts

The effect of storage delay and storage temperature on orthopaedic surgical samples contaminated by Staphylococcus Epidermidis

Effect of low-temperature preparation on the biological characteristics of adipose-derived mesenchymal stem cells

Optimizing mycobacteria molecular diagnostics: No decontamination! Human DNA depletion? Greener storage at 4 °C!

Efficacy assessment of different cryoprotectants for preserving the viability of Enterobacterales strains at - 20 °C

Optimization of microorganism preservation conditions for the development of an acute toxicity bioassay for biocides

Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring

Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality

Enhancing the Antibacterial Efficacy of Low-Dose Gentamicin with 5 Minute Assistance of Photothermy at 50 °C

Prolonged cold ischemia time in mouse heart transplantation using supercooling preservation.

Defining the shelf-life of calcium sulfate beads embedded with tobramycin and vancomycin

Proliferation of psychrotrophic bacteria in cold-stored platelet concentrates

Novel perspective on a conventional technique: Impact of ultra-low temperature on bacterial viability and protein extraction

Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers